SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in micePamela Becherini, Alessio Nencioni, Irene Caffa et al.|Cancer & Metabolism|2021Cited by 45
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug DiscoveryMoustafa Ghanem, Francesco Piacente, Alessio Nencioni et al.|Pharmaceuticals|2022Cited by 20
Structure-Based Identification and Biological Characterization of New NAPRT InhibitorsJorge Franco, Alberto Del Río, Andrea Benzi et al.|Pharmaceuticals|2022Cited by 12
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myelomaDebora Soncini, Michele Cea, Mario Passalacqua et al.|Blood Advances|2024Cited by 5